Treatment of Guillain-Barré syndrome with corticosteroids: Lack of benefit?

Lancet

Volumn 363, Issue 9404, 2004, Pages 181-182

  Hughes, Richard A C ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PLACEBO;

AGE DISTRIBUTION; CLINICAL TRIAL; CORTICOSTEROID THERAPY; DISABILITY; DISEASE SEVERITY; DOSE RESPONSE; GUILLAIN BARRE SYNDROME; HUMAN; META ANALYSIS; NOTE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZATION; SCALE UP; STANDARDIZATION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

EID: 1642493763     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)15367-6     Document Type: Note

References (10)

1. Hughes R.A.C., Newsom-Davis J.M., Perkin G.D., Pierce J.M. Controlled trial of prednisolone in acute polyneuropathy. Lancet. 2:1978;750-753.
2. Hughes RAC, van der Meché FGA. Corticosteroid treatment for Guillain-Barré syndrome (Cochrane Review). Chichester, UK: John Wiley & Sons Ltd, The Cochrane Library, Issue 4, 2003.
3. Double-blind trial of intravenous methylprednisolone in Guillain-Barré syndrome. Lancet. 341:1993;586-590.
4. Hughes R.A.C., Wijdicks E., Barohn R.J., et al. Practice parameter. Immunotherapy for Guillain-Barré syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 61:2003;736-740.
5. Rich M.M., Pinter M.J., Craner S.D., Barchi R.L. Loss of electrical excitability in an animal model of acute quadriplegic myopathy. Ann Neurol. 43:1998;171-179.
6. King R.H.M., Craggs R.I., Gross M.L.P., Thomas P.K. Effects of glucocorticoids on experimental allergic neuritis. Exp Neurol. 87:1985;9-19.
7. Watts P.M., Taylor W.A., Hughes RAC. High-dose methylprednisolone suppresses experimental allergic neuritis in the Lewis rat. Exp Neurol. 103:1989;101-104.
8. Donaghy M., Mills K.R., Boniface S.J., et al. Pure motor demyelinating neuropathy: deterioration after steroid treatment and improvement with intravenous immunoglobulin. J Neurol Neurosurg Psychiatry. 57:1994;778-783.
9. Hughes RAC, Raphael J-C, Swan AV, van Doorn PA. Intravenous immunoglobulin for Guillain-Barré syndrome (Cochrane Review). Chichester, UK: John Wiley & Sons Ltd, The Cochrane Library, Issue 4, 2003.
10. Raphael J-C, Chevret S, Hughes RAC, Annane D. Plasma exchange for Guillain-Barré Syndrome (Cochrane Review). Chichester, UK: John Wiley & Sons Ltd, The Cochrane Library Issue 4, 2003.